NCT06062823 Study of EGFR TKI in Patients With Advanced NSCLC Harbouring EGFR Mutations Status RECRUITING Phase PHASE2
NCT06054191 Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations Status NOT_YET_RECRUITING Phase PHASE2
NCT06051695 A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Status RECRUITING Phase PHASE1/PHASE2
NCT06050980 Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation Status RECRUITING Phase PHASE1
NCT06050278 Prospective Evaluation of Single Cell Mutations in a Panel of Known Oncogenes in NSCLC Surgical Specimens Status RECRUITING Phase N/A
NCT06043817 First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations Status RECRUITING Phase PHASE1/PHASE2
NCT06032936 BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutations Status TERMINATED Phase PHASE1
NCT06029816 Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations Status NOT_YET_RECRUITING Phase PHASE2
NCT06020352 The Efficacy and Safety of KN046 Combined With Axitinib Status UNKNOWN Phase PHASE2/PHASE3
NCT06001671 Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC Status COMPLETED Phase PHASE1
NCT05994131 IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC Status RECRUITING Phase PHASE1/PHASE2
NCT05991206 A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC Status RECRUITING Phase N/A
NCT05991193 A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer Status RECRUITING Phase N/A
NCT05988697 Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib Status NOT_YET_RECRUITING Phase N/A
NCT05987644 Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements Status RECRUITING Phase PHASE1/PHASE2
NCT05987345 Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer Status RECRUITING Phase NA
NCT05948813 TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases Status RECRUITING Phase PHASE2